MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Optimi Health Corp (OP:OPTHF)

0.2278 +0.0002 (+0.09%)
Streaming Delayed Price Updated: 1:54 PM EST, Feb 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,525
Open 0.2234
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.2276
Today's Range 0.2234 - 0.2278
52wk Range 0.1000 - 0.2934
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Optimi Health Completes First 2026 Production of MD-MA and Psilo Capsules
(January 26, 2026) - Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of pharmaceutical psychedelic drug 
Via PressReach
News headline image
Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition ↗
Psyence Biomed launches Phase IIb trials for psilocybin in palliative care and Alcohol Use Disorder, bolstering its clinical pipeline with key acquisitions and partnerships. 
Via Benzinga

Performance

YTD
-1.0%
-1.0%
1 Month
+3.2%
+3.2%
3 Month
-3.8%
-3.8%
6 Month
+109.2%
+109.2%
1 Year
+57.1%
+57.1%

More News

Read More
News headline image
New Milestone In Psychedelics Market: Canadian Start-Up Will Export Psilocybin And MDMA To Australia ↗
Via Benzinga
News headline image
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More ↗
Via Benzinga
News headline image
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More ↗
Via Benzinga
News headline image
Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute ↗
Via Benzinga
News headline image
Two Top Biotechs Forge MDMA Supply Deals For Clinical Research ↗
Via Benzinga
News headline image
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review ↗
Via Benzinga
News headline image
Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More ↗
Via Benzinga
News headline image
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More ↗
Via Benzinga
News headline image
Psychedelics Headlines: Magic Mushrooms For Sexual Wellbeing, The DEA's Stance, The Therapist's Role & More ↗
Via Benzinga
News headline image
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing ↗
Via Benzinga
News headline image
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More ↗
Via Benzinga
News headline image
Natural Psilocybin Companies Diversify: Latest By Optimi, Red Light Holland And A European Player ↗
Via Benzinga
News headline image
MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University ↗
Via Benzinga
News headline image
Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More ↗
Via Benzinga
News headline image
The Psychedelic Mushrooms Market; Between Legitimate Harvesting And Illegal Retail Sales ↗
Via Benzinga
News headline image
Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More ↗
Via Benzinga
News headline image
Optimi Health Boosts Psilocybin Production With New Health Canada License And Supply Deal ↗
Via Benzinga
News headline image
What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry ↗
Via Benzinga
News headline image
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More ↗
Via Benzinga
News headline image
Australia Receives First Batch Of Clinical-Grade Psilocybin From Mindset Pharma And PharmAla ↗
Via Benzinga
News headline image
Latest Psychedelics Deals: Optimi Supplies Australia, Awakn Partners Licensing In California ↗
Via Benzinga
News headline image
Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More ↗
Via Benzinga

Frequently Asked Questions

Is Optimi Health Corp publicly traded?
Yes, Optimi Health Corp is publicly traded.
What exchange does Optimi Health Corp trade on?
Optimi Health Corp trades on the OTC Traded
What is the ticker symbol for Optimi Health Corp?
The ticker symbol for Optimi Health Corp is OPTHF on the OTC Traded
What is the current price of Optimi Health Corp?
The current price of Optimi Health Corp is 0.2278
When was Optimi Health Corp last traded?
The last trade of Optimi Health Corp was at 02/02/26 01:54 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story